Urogenital Tuberculosis: Epidemiology, Diagnosis, Therapy (PDF)

Name: Urogenital Tuberculosis: Epidemiology, Diagnosis, Therapy
Brand: Springer-Verlag GmbH
SKU: 58092024
Price: 98.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Autor: Ekaterina Kulchavenya

Schreiben Sie einen Kommentar zu "Urogenital Tuberculosis: Epidemiology, Diagnosis, Therapy".

Urogenital Tuberculosis: Epidemiology, Diagnosis, Therapy, Ekaterina Kulchavenya

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 98.99 €

Buch (Gebunden) 109.99 €

sofort als Download lieferbar

Bestellnummer: 58092024

Printausgabe 109.99 €

eBook (pdf) -10% 98.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Urogenital Tuberculosis: Epidemiology, Diagnosis, Therapy (PDF)“

Many years ago the famous Russian TB-urologist professor Vilghelm Grund called Urogenital Tuberculosis (UGTB) a "great hoaxer", and until today UGTB is an unsolved problem. Clinical features of UGTB are flexible and variable, UGTB mimics numerous other diseases that result in delayed diagnosis. This book approaches the classification, pathogenesis, diagnostic, therapy and surgery for kidney tuberculosis as well as male genital tuberculosis. The reader will find recent data on epidemiology, many interesting history cases with illustrations and new methods for the identification of Mycobacterium tuberculosis.

Autoren-Porträt von Ekaterina Kulchavenya

Ekaterina Kulchavenya is a principal researcher of Novosibirsk Research TB Institute and professor of Novosibirsk Medical University. She has published more than 55 papers in reputed journals and 8 monographs and she is an author of chapters on urogenital tuberculosis in Russian National Guideline on Urology and in International Consultation on Urological Diseases. Prof. Kulchavenya is an author of many new patented techniques which significantly improved the therapy for extrapulmonary tuberculosis as well as prostate and bladder diseases.